Caribou Biosciences (CRBU) Interest Expenses (2020 - 2026)

Caribou Biosciences (CRBU) has 7 years of Interest Expenses data on file, last reported at $1.7 million in Q1 2026.

• On a quarterly basis, Interest Expenses rose 5393.55% year-over-year to $1.7 million in Q1 2026; TTM through Mar 2026 was $1.7 million, a 5393.55% increase from a year earlier, with the FY2025 full-year figure at $186.9 million, up 26.87% from the prior year.
• Interest Expenses for Q1 2026 stood at $1.7 million, up from $466000.0 in the prior quarter.
• Over the last five years, Interest Expenses for CRBU reached as high as $47.2 million in Q2 2022 and fell as low as $31000.0 in Q1 2025.
• Historically, Interest Expenses has averaged $13.8 million across 5 years, with a median of $1.7 million in 2026.
• Across the five-year window, Interest Expenses slumped 99.92% in 2025 and jumped 5393.55% in 2026, its largest moves.
• Year by year, Interest Expenses stood at $1.0 million in 2022, then climbed by 11.93% to $1.1 million in 2023, then fell by 20.88% to $898000.0 in 2024, then tumbled by 48.11% to $466000.0 in 2025, then soared by 265.45% to $1.7 million in 2026.
• Per Business Quant data, the three most recent Interest Expenses figures were $1.7 million in Q1 2026, $466000.0 in Q4 2025, and $3.1 million in Q3 2025.